본문 바로가기
KERD
논문KCI 등재

비알코올성지방간의 유관 인자 임상 연구: 종양표지자, 심박변이도, 사상체질

Clinical Study on Nonalcoholic Fatty Liver Disease Related Factors: Tumor Marker, Heart Rate Variability, Sasang Constitution

박수정|권영미|주종천|곽시라|신뢰
사상체질면역의학회 (The Society of Sasang Constitution and Immune Medicine)|2019.06|사상체질면역의학회지 (Journal of Sasang Constitution and Immune Medicine)|제31권 제2호|pp. 22-30|DOI https://doi.org/10.7730/JSCM.2019.31.2.22

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

metabolic syndromeSasang constitutionheart rate variabilityrelated factornonalcoholic fatty liver diseasealpha-feto protein
주제분류한의학

초록

Objectives The aim of this study is to investigate the related factors of nonalcoholic fatty liver disease (NAFLD). Methods The subjects were 187 persons diagnosed as fatty liver by abdominal ultrasonography. They were divided into three groups according to the severity of fatty liver: control, mild, moderate or severe. The three groups' general characteristics, laboratory results, liver function indexes, metabolic syndrome indexes, tumor markers, heart rate variability values and Sasang constitution distribution were compared and analyzed. Results Male ratio, height, weight, body mass index, red blood cell count, hemoglobin level and creatinine level were higher in NAFLD groups than in control group. The levels of sodium and amylase were higher in control than in NAFLD. In liver function, the levels of aspartate transaminase, alanine transaminase and gamma-glutamyl transpepsidase of NAFLD were higher. In metabolic syndrome index, systolic blood pressure, diastolic blood pressure, waist circumference, total cholesterol, triglyceride and low density lipoprotein cholesterol levels were higher in NAFLD, while high density lipoprotein cholesterol level was higher in control. The alpha-feto protein level was higher in NAFLD, and the heart rate variability was not different between NAFLD and control groups. In Sasang constitution, Taeeumin ratio of NAFLD was higher than of control. Conclusions The results suggest that nonalcoholic fatty liver is clinically related to liver dysfunction, metabolic syndrome, tumor markers, and Sasang constitution. Further studies are needed to control nonalcoholic fatty liver disease and prevent severe disease such as cirrhosis and cancer caused by fatty liver.

Abstract

Objectives The aim of this study is to investigate the related factors of nonalcoholic fatty liver disease (NAFLD). Methods The subjects were 187 persons diagnosed as fatty liver by abdominal ultrasonography. They were divided into three groups according to the severity of fatty liver: control, mild, moderate or severe. The three groups' general characteristics, laboratory results, liver function indexes, metabolic syndrome indexes, tumor markers, heart rate variability values and Sasang constitution distribution were compared and analyzed. Results Male ratio, height, weight, body mass index, red blood cell count, hemoglobin level and creatinine level were higher in NAFLD groups than in control group. The levels of sodium and amylase were higher in control than in NAFLD. In liver function, the levels of aspartate transaminase, alanine transaminase and gamma-glutamyl transpepsidase of NAFLD were higher. In metabolic syndrome index, systolic blood pressure, diastolic blood pressure, waist circumference, total cholesterol, triglyceride and low density lipoprotein cholesterol levels were higher in NAFLD, while high density lipoprotein cholesterol level was higher in control. The alpha-feto protein level was higher in NAFLD, and the heart rate variability was not different between NAFLD and control groups. In Sasang constitution, Taeeumin ratio of NAFLD was higher than of control. Conclusions The results suggest that nonalcoholic fatty liver is clinically related to liver dysfunction, metabolic syndrome, tumor markers, and Sasang constitution. Further studies are needed to control nonalcoholic fatty liver disease and prevent severe disease such as cirrhosis and cancer caused by fatty liver.

참고문헌 (31)

  1. Sweet PH, "Nonalcoholic Fatty Liver Disease", Primary care, 44(4), pp.599~607 (2017)
  2. Tanaka N, "Current status, problems, and perspectives of non-alcoholic fatty liver disease research", World journal of gastroenterology, 25(2), pp.163~177 (2019)
  3. Farrell GC, "Nonalcoholic fatty liver disease:from steatosis to cirrhosis", Hepatology, 43(2Suppl 1), pp.S99~S112 (2006)
  4. Kotronen A, "Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors", Gastroenterology, 137(3), pp.865~872 (2009)
  5. Kim JS, "A Study on the Diagnosis of Fatty Liver by Ultrasonography", J of East-West Medicines, 25(3), pp.56~74 (2000)
  6. Neuschwander-Tetri BA, "Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease", Hepatology, 52(3), pp.913~924 (2010)
  7. Massoud O, "Nonalcoholic Fatty Liver Disease", Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma, 2018, pp.22(1), 201~211
  8. Kumar MS, "Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease", International journal of hepatology, 2016, pp.5160754~ (2016)
  9. Lee SK, "Non-alcoholic fatty liver disease among sasang constitutional types: a population-based study in Korea", BMC complementary and alternative medicine, 15, pp.399~ (2015)
  10. Kang MJ, "Prevalence and Risk Factors of the Non alcoholic Fatty Liver Disease according to the Sasang Constitutional types", pp.2012
  11. 박연화, "비알콜성지방간의 유병율과 병리기전에 대한 문헌적 고찰", 대한한방내과학회지, 32(1), pp.26~32 (2011), 대한한방내과학회
  12. Stahl EP, "Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review", Journal of the American College of Cardiology, 73(8), pp.948~963 (2019)
  13. Giannini EG, "Liver enzyme alteration:a guide for clinicians", Canadian Medical Association Journal, 172(3), pp.367~379 (2005)
  14. Ren XY, "Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study", Lipids in health and disease, 18(1), pp.47~ (2019)
  15. Briseno-Bass P, "Prevalence of liver steatosis and its relation to liver function tests and lipid profile in patients at medical check-up", Revista de gastroenterologia de Mexico, ~ (2018)
  16. Wu EM, "Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease", steatohepatitis and liver transplantation, 2018, pp.4, 66~
  17. Nampoothiri RV, "Renal Dysfunction in Patients With Nonalcoholic Fatty Liver Disease is Related to the Presence of Diabetes Mellitus and Severity of Liver Disease", Journal of clinical and experimental hepatology, 9(1), pp.22~28 (2019)
  18. Nakajima K, "Independent association between low serum amylase and non-alcoholic fatty liver disease in asymptomatic adults: a cross-sectional observational study", BMJ open, 3(1) (2013)
  19. Yao J, "Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients", Lipids in health and disease, 13, pp.185~ (2014)
  20. Mantovani A, "Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis", Thyroid : official journal of the American Thyroid Association, 28(10), pp.1270~1284 (2018)
  21. Duan XY, "Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma", Hepatobiliary Pancreat Dis Int, 11(1), pp.18~27 (2012)
  22. Beale G, "AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease", BMC Cancer, 8, pp.200~ (2008)
  23. Yki-Jarvinen H, "Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome", The lancet Diabetes & endocrinology, 2(11), pp.901~910 (2014)
  24. Wong CR, "Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease", World journal of gastroenterology, 22(37), pp.8294~8303 (2016)
  25. Almanza D, "Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature", Digestive diseases and sciences (2018)
  26. Bertot LC, "Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease", Expert review of gastroenterology & hepatology, 13(2), pp.179~187 (2019)
  27. Margini C, "The story of HCC in NAFLD:from epidemiology, across pathogenesis, to prevention and treatment", Liver international : official journal of the International Association for the Study of the Liver, 36(3), pp.317~324 (2016)
  28. Kwak MS, "Nonalcoholic fatty liver disease is associated with breast cancer in nonobese women", Digestive and Liver Disease, ~ (2019)
  29. Liu YC, "Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability", PloS one, 8(4), pp.e61803~ (2013)
  30. Lee HY, "A Systematic Review on Sasang Constitutional Type-Associated Susceptibility to Disorders in Korea", J Altern Complement Med, 22(12), pp.950~956 (2016)
  31. Lee J, "Cancer incidence varies significantly depending on Sasang constitution of Traditional Korean Medicine", J Tradit Chin Med, 33(3), pp.312~315 (2013)

관련 논문AI추천

사상체질별 간기능 검사 및 초음파상의 간질환에 대한 연구김민지, 박성식, 배효상사상체질면역의학회 · 사상체질면역의학회지2013 · 제25권 제3호일부 종합검진 수검자 중 비알코올성 지방간과 심혈관질환 위험요인과의 관련성박용상, 유재희, 이강숙, 이선영, 홍아름대한예방의학회 · 예방의학회지2008 · 제41권 제6호비알코올성 지방간과 대사증후군 및 혈청 카로테노이드와의 관련성김성애, 김성희, 박선균, 손효경, 이덕희, 이성국, 이현정, 이혜성, 천병렬대한예방의학회 · 예방의학회지2008 · 제41권 제1호심혈관계 위험인자로서의 비알코올지방간질환; 경동맥 동맥경화와의 상관관계강진화, 김동희, 김영선, 김충현, 박민정, 이효석, 임선희, 최수연대한간학회 · Clinical and Molecular Hepatology2008 · 제14권 제1호비알콜성 지방간질환의 한방치료에 대한 체계적 문헌고찰김경순, 김승모, 이유리, 조나경, 최홍식대한한방내과학회 · 대한한방내과학회지2019 · 제40권 제1호성인 남성에서 진단된 지방간 정도와 혈액학적 검사 및비만지표의 상관관계공창기, 곽종길, 문일봉(사)한국방사선산업학회 · 방사선산업학회지2021 · 제15권 제1호

이 간행물의 다른 논문 (3건)

사상체질과 식습관 특성에 따른 연구 동향백영화, 이시우, 정경식pp. 1-111년간 검사-재검사법을 통한 단축형 사상체질 진단 설문(KS-15)의 신뢰도 평가김상혁, 이수진, 배광호, 고호연, 이시우, 박기현pp. 12-21원발성 중추신경계 림프종으로 항암화학요법 후 발생한 자한, 심계정충을 호소하는 소음인 치험 1례이용재, 이미숙, 이슬pp. 31-40
원문 보기